😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Enhabit shareholders approve board nominees and executive compensation

EditorBrando Bricchi
Published 2024-07-26, 05:50 p/m
EHAB
-

DALLAS, TX – Enhabit, Inc., a provider of home health care services, announced the results of its Annual Meeting of Stockholders held on Thursday. The company, listed on the New York Stock Exchange under the ticker NYSE:EHAB, confirmed the election of its board of directors and the ratification of its independent accountants.

During the meeting, shareholders voted on several key proposals. The first proposal involved the election of the company's board of directors for a one-year term expiring at the 2025 Annual Meeting of Stockholders. All of the company's nominees were elected, with Jeffrey W. Bolton and Barbara A. Jacobsmeyer receiving the highest number of votes for their positions, while nominees from AREX, a separate entity, received significantly fewer votes.

The second proposal for the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, passed with overwhelming support.

A third proposal, an advisory vote on the compensation of the company's named executive officers, also passed with a majority of votes in favor.

The voting outcomes reflect shareholder confidence in the current management and strategic direction of Enhabit, Inc. The company's business address is 6688 N. Central Expressway, Suite 1300, Dallas, Texas, and it operates under the SIC code 8082, which pertains to home health care services.

The information presented in this article is based on a press release statement.

In other recent news, Enhabit, Inc. has reported strong Q2 preliminary results, expecting an Adjusted EBITDA of $24.5 million to $25.0 million and announcing a significant $15 million reduction in bank debt. In the midst of these financial improvements, AREX Capital Management, a major shareholder, has proposed seven new director nominees for Enhabit's board, expressing dissatisfaction with the company's direction. Despite this, Enhabit defended its current board, emphasizing recent improvements and urging shareholders to back its nominees. The company also received support from Institutional Shareholder Services for most of its director nominees. In addition, Enhabit stockholders have preliminarily voted to elect eight of its director nominees for the upcoming year, including one nominee from AREX Capital Management. These results are subject to final tabulation and certification. These are recent developments in the ongoing dynamics within Enhabit as the company navigates financial performance and governance issues.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.